You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click
OK. If you do not, click Cancel.
Back to top
Latest Performance as of Dec 31, 2017
Total Return %*
Percentile Rank Objective
* Annual for three years and beyond.
Mutual Funds Research & Tools
Search Similar Mutual Funds
Research similar Mutual Funds with higher ranks and performance ratings.
Mutual Funds Comparison View (minimum of 2)
Mutual Funds Screener
Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best
Screen meet your unique criteria.
%Unrealized Gain YTD
% SEC Yield
Net Assets (Mil $) 12/31/2017
Sector / Country Weightings
As of 12/31/2017
% of Portfolio
Top Equity Holdings
(As of 10/31/2017) % of Portfolio
GILEAD SCIENCES INC
BIOGEN IDEC INC
VERTEX PHARMACEUTICALS IN 3.41
ALEXION PHARMACEUTICALS I 2.47
Stock Holding % of Net Assets
Avg. EPS Growth
Avg. Market Value (Mil $)
% of Portfolio
High Yield Bond
Chart for Biotechnology Ultra Sector Pro Fund, Service BIPSX
Zacks News for BIPSX
No Record found.
Other News for BIPSX
No Record found.
%Max Sales Load
%Max Deferred Load
%Max 12b-1 Fee
%Max Management Fee
The fund was incepted in June 2000 and is managed by ProFund Advisors. The fund seeks daily investment results that correspond to 150%, before fees and expenses, of the performance of the Dow Jones U.S. Biotechnology Index. The fund primarily invests in biotechnology companies. It concentrates investments in a particular industry or group of industries to approximately the same extent the Index is concentrated. The fund may invest in equity caps, collars and floors, swaps, American Depositary Receipts and options on securities and securities indices. Dividends and capital gains are distributed annually.
Zacks Research is Reported On:
Copyright 2018 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25% per year. These returns cover a period from 1988-2016 and were examined and attested by Baker Tilly Virchow Krause, LLP, an independent accounting firm. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zack Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
performance for information about the performance numbers displayed above.
www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by FIS.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.